GLPG
NASDAQ
$27.73
Galapagos NV (GLPG)
Galapagos NV, a clinical-stage biotechnology company, discovers, develops and markets several small molecule drugs. The company is headquartered in Mechelen, Belgium.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $28.56 (+2.99%)
Market Cap
$1.90B
PEG Ratio
0.01
P/B Ratio
0.49
Profit Margin
86.8%
Price Chart
Valuation
Market Cap$1.90B
P/E4.86
Forward P/E344.83
PEG0.01
P/S1.74
P/B0.49
Profitability
Total Revenue (TTM)$1.31B
Gross Profit (TTM)$732M
EBITDA$343M
Profit Margin86.8%
Operating Margin84.2%
EPS$5.93
Financial Health
Debt-to-Equity0.4%
Free Cash Flow Yield-16.24%
Growth & Risk
Revenue 5Y CAGR+19.11%
FCF 5Y CAGR-12.44%
Beta (5Y)0.50
Sharpe Ratio0.21